BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19803001)

  • 1. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
    Wittmann DH; Schassan HH; Kohler F; Seibert W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.
    Rodvold KA; Gotfried MH; Cwik M; Korth-Bradley JM; Dukart G; Ellis-Grosse EJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1221-9. PubMed ID: 17012300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
    Womble AY; Giguère S; Lee EA; Vickroy TW
    Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of ertapenem into bone and synovial tissues.
    Boselli E; Breilh D; Djabarouti S; Bel JC; Saux MC; Allaouchiche B
    J Antimicrob Chemother; 2007 Oct; 60(4):893-6. PubMed ID: 17704514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ertapenem peritoneal fluid concentrations in adult surgical patients.
    Arrigucci S; Garcea A; Fallani S; Cassetta MI; Canonico G; Tonelli F; Mazzei T; Novelli A
    Int J Antimicrob Agents; 2009 Apr; 33(4):371-3. PubMed ID: 19097758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics and tissue penetration of teicoplanin.
    Novelli A; Mazzei T; Reali EF; Mini E; Periti P
    Int J Clin Pharmacol Res; 1989; 9(3):233-7. PubMed ID: 2526102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.
    Wise ER; Armstrong GC; Brown RM; Andrews JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():277-82. PubMed ID: 19802998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime: experimental and clinical evaluation of biliary elimination.
    Brogard JM; Jehl F; Monteil H; Blickle JF; Arnaud JP
    Drugs Exp Clin Res; 1987; 13(2):105-14. PubMed ID: 3556121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drago L; De Vecchi E; Fassina MC; Gismondo MR
    Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.
    Barth J; Jäger D; Mundkowski R; Drewelow B; Welte T; Burkhardt O
    J Antimicrob Chemother; 2008 Sep; 62(3):575-8. PubMed ID: 18515790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Availability of cefotaxime. Pharmacokinetic studies on the distribution in central and various peripheral compartments (author's transl)].
    Wittmann DH; Schassan HH; Welter J; Seidel H
    MMW Munch Med Wochenschr; 1980 Apr; 122(17):637-41. PubMed ID: 6248774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation.
    Conil JM; Georges B; Lavit M; Laguerre J; Samii K; Houin G; Saivin S
    Br J Clin Pharmacol; 2007 Jul; 64(1):27-35. PubMed ID: 17324245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
    Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
    Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals.
    Womble A; Giguère S; Lee EA
    J Vet Pharmacol Ther; 2007 Jun; 30(3):187-93. PubMed ID: 17472649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers.
    Adamis G; Papaioannou MG; Giamarellos-Bourboulis EJ; Gargalianos P; Kosmidis J; Giamarellou H
    Int J Antimicrob Agents; 2004 Feb; 23(2):144-9. PubMed ID: 15013039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of ceftazidime into extracellular fluid in patients.
    Hoffstedt B; Walder M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():289-92. PubMed ID: 19803000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.